Secoisolariciresinol Diglycoside (SDG)
An ingredient in flaxseed and other plant-based foods is a lignan called secoisolariciresinol diglycoside (SDG). SDG is transformed by the body into enterolactone, an estrogenic-active molecule. Numerous health advantages, such as cancer prevention, enhanced cardiovascular health, and diminished menopausal symptoms, have been associated with SDG and enterolactone.A weak estrogen agonist/antagonist, enterolactone. Enterolactone has been found to lower the risk of breast cancer in premenopausal women. Enterolactone may prevent bone loss in postmenopausal women.Improved cardiovascular health has also been connected to SDG and enterolactone. These molecules might lower blood pressure and cholesterol levels. They could also aid in preventing blood clots from forming. Welzo users can use this article for informational purposes to better understand SDG.
